SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-044143
Filing Date
2015-02-11
Accepted
2015-02-11 16:02:59
Documents
1
Group Members
HEALTHCAP IV BIS, L.P.HEALTHCAP IV, K.B.OFCO CLUB IV

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d869081dsc13ga.htm SC 13G/A 83246
  Complete submission text file 0001193125-15-044143.txt   84610
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87623 | Film No.: 15599538
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 18 AVENUE DOUCHY CH1006 LAUSANNE V8 00000
HEALTHCAP IV LP (Filed by) CIK: 0001178496 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A